Key Points
- Paysign CEO Mark Newcomer sold 50,000 shares at an average price of $15.34, generating $767,000. The transaction was made under a pre-arranged Rule 10b5-1 trading plan, leaving him with 9.11 million shares.
- Paysign recently reported stronger-than-expected quarterly results, with earnings of $0.11 per share versus the $0.06 consensus estimate and revenue of $28.25 million. Management provided fiscal 2026 EPS guidance of $0.35–$0.37.
- The stock opened at $15.16 and has risen substantially from its one-year low of $3.08; analysts maintain a “Buy” consensus with an average price target of $15.00.
Paysign, Inc. (NASDAQ:PAYS - Get Free Report) CEO Mark Newcomer sold 50,000 shares of Paysign stock in a transaction that occurred on Friday, October 9th. The shares were sold at an average price of $15.34, for a total transaction of $767,000.00. Following the sale, the chief executive officer owned 9,113,002 shares of the company's stock, valued at approximately $139,793,450.68. The trade was a 0.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Mark Newcomer also recently made the following trade(s):
- On Thursday, August 6th, Mark Newcomer sold 150,000 shares of Paysign stock. The stock was sold at an average price of $11.88, for a total transaction of $1,782,000.00.
- On Wednesday, July 29th, Mark Newcomer sold 50,000 shares of Paysign stock. The stock was sold at an average price of $9.38, for a total transaction of $469,000.00.
Paysign Price Performance
Shares of NASDAQ:PAYS opened at $15.16 on Thursday. The company's fifty day moving average price is $13.34 and its 200-day moving average price is $9.37. The firm has a market capitalization of $855.96 million, a price-to-earnings ratio of 58.31 and a beta of 0.83. Paysign, Inc. has a one year low of $3.08 and a one year high of $15.62.
Paysign (NASDAQ:PAYS - Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.05. Paysign had a net margin of 15.67% and a return on equity of 30.13%. The firm had revenue of $28.25 million for the quarter, compared to analysts' expectations of $26.36 million. Paysign has set its FY 2026 guidance at 0.350-0.370 EPS and its Q3 2026 guidance at 0.090-0.100 EPS. As a group, equities research analysts expect that Paysign, Inc. will post 0.58 EPS for the current year.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Legal & General Group Plc purchased a new position in shares of Paysign during the second quarter worth approximately $35,000. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Paysign by 381.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 9,876 shares of the company's stock worth $51,000 after acquiring an additional 7,825 shares during the last quarter. EFG International AG purchased a new stake in shares of Paysign in the 2nd quarter valued at $68,000. Quantbot Technologies LP purchased a new stake in shares of Paysign in the 2nd quarter valued at $97,000. Finally, The Manufacturers Life Insurance Company purchased a new stake in shares of Paysign in the 2nd quarter valued at $100,000. 25.89% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on PAYS. Weiss Ratings upgraded Paysign from a "buy (b-)" rating to a "buy (b)" rating in a research report on Thursday, October 8th. Barrington Research set a $15.00 price target on Paysign in a research note on Tuesday, August 11th. Lake Street Capital upped their price objective on Paysign from $13.00 to $15.00 and gave the stock a "buy" rating in a report on Tuesday, September 15th. DA Davidson upped their price objective on Paysign from $12.00 to $15.00 and gave the stock a "buy" rating in a report on Wednesday, September 30th. Finally, Wall Street Zen lowered Paysign from a "strong-buy" rating to a "buy" rating in a research report on Sunday, August 16th. Three equities research analysts have rated the stock with a Buy rating. According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $15.00.
Get Our Latest Report on Paysign
Paysign Company Profile
(
Get Free Report)
Paysign, Inc (NASDAQ: PAYS) provides prepaid payment and financial technology solutions, with a focus on healthcare, pharmaceutical and other specialized markets. Its platform supports the issuance and management of prepaid cards, digital payments, account services and related payment-processing activities.
The company's healthcare offerings include patient assistance and copay programs that help pharmaceutical manufacturers distribute financial support to eligible patients. Paysign also provides payment and card solutions for plasma collection centers, including programs used to compensate plasma donors.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
